Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 36, 2022 - Issue 16
427
Views
5
CrossRef citations to date
0
Altmetric
Research Articles

A new anti-tumor cytotoxic triterpene from Ganoderma lucidum

, , , , , & show all
Pages 4125-4131 | Received 30 Mar 2021, Accepted 27 Aug 2021, Published online: 20 Sep 2021

References

  • Chanvorachote P, Chamni S, Ninsontia C, Phiboonchaiyanan PP. 2016. Potential Anti-metastasis Natural Compounds for Lung Cancer. Anticancer Res. 36(11):5707–5717.
  • Cizmarikova M. 2017. The Efficacy and Toxicity of Using the Lingzhi or Reishi Medicinal Mushroom, Ganoderma lucidum (Agaricomycetes), and Its Products in Chemotherapy (Review). Int J Med Mushrooms. 19(10):861–877.
  • Jin X, Ruiz Beguerie J, Sze DM, Chan GC. 2016. Ganoderma lucidum (Reishi mushroom) for cancer treatment. Cochrane Database Syst Rev. 4(4):Cd007731.
  • Kikuchi T, Matsuda S, Kadota S, Murai Y, Ogita ZJC, Bulletin P. 1985. Ganoderic acid D, E, F, and H and lucidenic acid D, E, and F, new triterpenoids from Ganoderma lucidum. Chem Pharm Bull. 33(6):2624–2627.
  • Koo MH, Chae HJ, Lee JH, Suh SS, Youn UJ. 2019. Antiinflammatory lanostane triterpenoids from Ganoderma lucidum. Nat Prod Res. 24:1–8.
  • Li P, Deng YP, Wei XX, Xu JH. 2013. Triterpenoids from Ganoderma lucidum and their cytotoxic activities. Nat Prod Res. 27(1):17–22.
  • Rawat D, Shrivastava S, Naik RA, Chhonker SK, Mehrotra A, Koiri RK. 2018. An Overview of Natural Plant Products in the Treatment of Hepatocellular Carcinoma. Anticancer Agents Med Chem. 18(13):1838–1859.
  • Sanodiya BS, Thakur GS, Baghel RK, Prasad GB, Bisen PS. 2009. Ganoderma lucidum: a potent pharmacological macrofungus. Curr Pharm Biotechnol. 10(8):717–742.
  • Sohretoglu D, Huang S. 2018. Ganoderma lucidum Polysaccharides as An Anti-cancer Agent. Anticancer Agents Med Chem. 18(5):667–674.
  • Tong JB, Zhang XX, Wang XH, Zeng SJ, Wang DY, Zhang ZQ, Hu J, Yang C, Li ZG. 2018. Qiyusanlong decoction suppresses lung cancer in mice via Wnt/β-catenin pathway. Mol Med Rep. 17(4):5320–5327.
  • Unlu A, Nayir E, Kirca O, Ozdogan M. 2016. Ganoderma Lucidum (Reishi Mushroom) and cancer. J Buon. 21(4):792–798.
  • Wu M, Shen CE, Lin QF, Zhong JY, Zhou YF, Liu BC, Xu JH, Zhang ZQ, Li P. 2021. Sterols and triterpenoids from Ganoderma lucidum and their reversal activities of tumor multidrug resistance. Nat Prod Res. 10:1–4.
  • Ye WY, Wang JZ, Deng GG, Dang YW, Liu HW, Chen G. 2020. Estrogenic activities of compound GL-1, isolated from Ganoderma lucidum. Nat Prod Res. 9:1–5.
  • Zeng P, Chen Y, Zhang L, Xing M. 2019. Ganoderma lucidum polysaccharide used for treating physical frailty in China. Prog Mol Biol Transl Sci. 163:179–219.
  • Zhang XQ, Ip FC, Zhang DM, Chen LX, Zhang W, Li YL, Ip NY, Ye WC. 2011. Triterpenoids with neurotrophic activity from Ganoderma lucidum. Nat Prod Res. 25(17):1607–1613.
  • Zolj S, Smith MP, Goines JC, Ali TS, Huff MO, Robinson DL, Lau JM. 2018. Antiproliferative Effects of a Triterpene-Enriched Extract from Lingzhi or Reishi Medicinal Mushroom, Ganoderma lucidum (Agaricomycetes), on Human Lung Cancer Cells. Int J Med Mushrooms. 20(12):1173–1183.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.